Patient Guide: A phase 3b study (NCT00855335) was conducted to investigate the pharmacokinetics (PK), efficacy, and safety of DRV/COBI during the 2nd and 3rd trimesters compared to PP in HIV-1 infected pregnant women.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT00855335
Status: COMPLETED_NEXT_PHASE_UPCOMING
Condition: HIV-1 infection
Phase: Phase III

Loading interactive enrollment tools...

The full interactive experience will load momentarily